S

Sigilon Therapeutics, Inc.

80 employees

Sigilon Therapeutics is a biotech company that specializes in creating immune-privileged products for treating acute and chronic diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
hemophilia
biotechnology
Health Care
chronic diseases
lysosomal storage disorders
cell therapy
Wellness
cell engineering
biocompatible materials
diabetes

Date founded

2015

Funding rounds raised

Total raised

$80M

from 2 investors over 2 rounds

S

Sigilon Therapeutics, Inc. raised $80M on March 17, 2020

Investors: Longevity Vision Fund and Flagship Ventures

FAQ